Global Journal of Medical Research, K: Interdisciplinary, Volume 22 Issue 3

13. Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, et al. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther [Internet]. 2004 Nov 1 [cited 2021 Jul 17]; 20(10): 1133–41. Available from: https://online library.wiley.com/doi/full/10.1111/j.1365-2036.2004. 02268.x 14. Cui H-H, Chen C-L, Wang J-D, Yang Y-J, Cun Y, Wu J-B, et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol [Internet]. 2004 May 15 [cited 2021 Jul 19]; 10(10): 1521. Available from: /pmc/articles/ PMC4656296/ 15. Oliva S, Di Nardo G, Ferrari F, Mallardo S, Rossi P, Patrizi G, et al. Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis. Aliment Pharmacol Ther [Internet]. 2012 Feb 1 [cited 2021 Dec 22]; 35(3):327–34. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1365 -2036.2011.04939.x 16. Palumbo VD, Romeo M, Gammazza AM, Carini F, Damiani P, Damiano G, et al. The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study. http://biomed.papers.upol.cz/doi/ 105507/bp2016044.html [Internet]. 2016 [cited 2021 Dec 22]; 160(3): 372–7. Available from: http://biomed.papers.upol.cz/doi/10.5507/bp.2016.0 44.html 17. Chen P, Xu H, Tang H, Zhao F, Yang C, Kwok LY, et al. Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis. Microb Biotechnol [Internet]. 2020 Nov 1 [cited 2021 Dec 22]; 13(6): 2032–43. Available from: https://onlinelibrary.wiley.com/doi/ full/10.1111/1751-7915.13661 18. Tamaki H, Nakase H, Inoue S, Kawanami C, Itani T, Ohana M, et al. Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial. Dig Endosc. 2016 Jan 1; 28(1): 67–74. 19. Santana Porbén S. Influencia de una combinación de lactobacilos + bifidobacterias sobre la actividad de la enfermedad, el hábito defecatorio y el estado nutricional de pacientes con colitis ulcerosa INFLUENCE OF A COMBINATION OF LACTOBACILLI AND BIFIDOBACTERIA UPON DISEASE ACTIVITY, STOOL PATTERN AND NUTRITIONAL STATUS OF ULCERATIVE COLITIS PATIENTS. Nutr Hosp. 2010; 25(6): 971–83. 20. Petersen AM, Mirsepasi H, Halkjær SI, Mortensen EM, Nordgaard-Lassen I, Krogfelt KA. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial. J Crohn’s Colitis [Internet]. 2014 Nov; 8(11): 1498– 505. Available from: https://academic.oup.com/ ecco-jcc/article-lookup/doi/10.1016/j.crohns.2014. 06.001 21. Ou Q, Wang L, Wang K, Shao P. Effect of probiotics supplementation combined with WeChat platform health management on nutritional status, inflammatory factors, and quality of life in patients with mild-to-moderate ulcerative colitis: a randomized trial. Ann Palliat Med [Internet]. 2021 Jun [cited 2021 Aug 1]; 10(6):6606616–6606616. Available from: https://apm.amegroups.com/ article/view/72489/html 22. GAMEDII. Retocolite Ulcerativa. Assist Multidiscip em Estomias e Doenças Inflamatórias Intest [Internet]. 2019 [cited 2021 May 8]; Available from: https://www.gamedii.com.br/retocolite-ulcerativa 23. Bjarnason I, Sission • Guy, Bu’ •, Hayee H. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease. 2019; 27: 465–73. Available from: https://doi.org/10.1007/s10787-019-00595-4 R eferências de A poio 1. Abdelouhab K, Rafa H, Toumi R, Bouaziz S, Medjeber O, Touil-Boukoffa C. Mucosal intestinal alteration in experimental colitis correlates with nitric oxide production by peritoneal macrophages: Effect of probiotics and prebiotics. Immunopharmacol Immunotoxicol [Internet]. 2012 Aug [cited 2021 May 6]; 34(4): 590–7. Available from: https://www. tandfonline.com/doi/abs/10.3109/08923973.2011.64 1971 2. Amaral JD do, Jesus ARB da S de. Uso terapêutico adjuvante de probióticos no efeito tardio da radioterapia pélvica: a retocolite ulcerativa. Braspen J [Internet]. 2018 [cited 2021 Dec 22];101–6. Available from: http://arquivos.braspen.org/journal/ jan-fev-mar-2018/16-AR-Uso-terapeutico-adjuvante. pdf 3. Braspen J [Internet]. 2018 [cited 2021 Dec 22]; 101–6. Available from: http://arquivos.braspen.org/ journal/jan-fev-mar-2018/16-AR-Usoterapeutico- adjuvante.pdf 4. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, et al. VSL#3 probiotic- mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol [Internet]. 2005 Jul [ cited 2021 Apr 27]; 100(7): 1539–46. Availab le from: https://pubmed.ncbi.nlm.nih.gov/15984978/ 5. Borruel N. Probióticos y prebióticos en la enfermedad inflamatoria intestinal. 2007; 30(7): 419–25. 6. CastañedaGuillot CD. Microbiota intestinal, probióticos y prebióticos. Enfermería Investig 51 Year 2022 Global Journal of Medical Research Volume XXII Issue III Version I ( D ) K © 2022 Global Journals The Therapeutic use of Probiotics in Patients with Ulceractive Retocolitis: A Systematic Review